Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;79:222-226

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, T.-T. T.
Right arrow Articles by Warshaw, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, T.-T. T.
Right arrow Articles by Warshaw, D. M.
(Circulation Research. 1996;79:222-226.)
© 1996 American Heart Association, Inc.


Articles

Maximal Actomyosin ATPase Activity and In Vitro Myosin Motility Are Unaltered in Human Mitral Regurgitation Heart Failure

The-Tin T. Nguyen, Eric Hayes, Louis A. Mulieri, Bruce J. Leavitt, Henk E.D.J. ter Keurs, Norman R. Alpert, David M. Warshaw

the Department of Medicine and Medical Physiology (T.-T.T.N., H.E.D.J. ter K.), University of Calgary (Canada), and the Department of Molecular Physiology and Biophysics (E.H., L.A.M., N.R.A., D.M.W.) and the Department of Medicine (B.J.L.), College of Medicine, University of Vermont, Burlington.

Myofibrillar but not actomyosin ATPase is depressed in failing myocardium from patients with dilated cardiomyopathy. Since there is a similar depression of myofibrillar ATPase in mitral regurgitation myocardium, we investigated whether or not the hydrolytic and mechanical performances of myosin are altered by comparing the maximal actomyosin ATPase activity and the in vitro myosin motility of myocardial myosin from patients with mitral regurgitation heart failure with that of patients with normal ventricular function. The results show that there is no significant difference (P>.05) between nonfailing and failing values for either the maximal actomyosin ATPase activity (0.3 s-1·head-1) or the myosin motility (1 µm/s). These observations suggest that changes, other than in the myosin heavy chain, contribute to the altered myocardial performance in mitral regurgitation myocardium.


Key Words: actin filament • biopsy • cardiomyopathy • cardiac muscle • crossbridge




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden
Sarcomeric dysfunction in heart failure
Cardiovasc Res, March 1, 2008; 77(4): 649 - 658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Krenz, S. Sadayappan, H. E. Osinska, J. A. Henry, S. Beck, D. M. Warshaw, and J. Robbins
Distribution and Structure-Function Relationship of Myosin Heavy Chain Isoforms in the Adult Mouse Heart
J. Biol. Chem., August 17, 2007; 282(33): 24057 - 24064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. S. Rao, L. R. La Bonte, Y. Xu, Z. Yang, B. A. French, and W. H. Guilford
Alterations to myofibrillar protein function in nonischemic regions of the heart early after myocardial infarction
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H654 - H659.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. P. Schmitt, E. P. Debold, F. Ahmad, A. Armstrong, A. Frederico, D. A. Conner, U. Mende, M. J. Lohse, D. Warshaw, C. E. Seidman, et al.
Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function
PNAS, September 26, 2006; 103(39): 14525 - 14530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. R. Alpert, S. A. Mohiddin, D. Tripodi, J. Jacobson-Hatzell, K. Vaughn-Whitley, C. Brosseau, D. M. Warshaw, and L. Fananapazir
Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1097 - H1102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, D. E. Fishbaugher, J. P. Schmitt, Y. Wang, N. R. Alpert, C. E. Seidman, J. G. Seidman, P. VanBuren, and D. W. Maughan
Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H91 - H99.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Krenz, A. Sanbe, F. Bouyer-Dalloz, J. Gulick, R. Klevitsky, T. E. Hewett, H. E. Osinska, J. N. Lorenz, C. Brosseau, A. Federico, et al.
Analysis of Myosin Heavy Chain Functionality in the Heart
J. Biol. Chem., May 2, 2003; 278(19): 17466 - 17474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. R. Alpert, C. Brosseau, A. Federico, M. Krenz, J. Robbins, and D. M. Warshaw
Molecular mechanics of mouse cardiac myosin isoforms
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1446 - H1454.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Noguchi, Z. Chen, S. P. Bell, L. Nyland, and M. M. LeWinter
Activation of PKC decreases myocardial O2 consumption and increases contractile efficiency in rats
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2191 - H2197.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Sanbe, J. Gulick, E. Hayes, D. Warshaw, H. Osinska, C.-B. Chan, R. Klevitsky, and J. Robbins
Myosin light chain replacement in the heart
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1355 - H1364.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Sanbe, D. Nelson, J. Gulick, E. Setser, H. Osinska, X. Wang, T. E. Hewett, R. Klevitsky, E. Hayes, D. M. Warshaw, et al.
In Vivo Analysis of an Essential Myosin Light Chain Mutation Linked to Familial Hypertrophic Cardiomyopathy
Circ. Res., August 18, 2000; 87(4): 296 - 302.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Regnier, A. J. Rivera, Y. Chen, and P. B. Chase
2-Deoxy-ATP Enhances Contractility of Rat Cardiac Muscle
Circ. Res., June 23, 2000; 86(12): 1211 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. J. Tyska, E. Hayes, M. Giewat, C. E. Seidman, J. G. Seidman, and D. M. Warshaw
Single-Molecule Mechanics of R403Q Cardiac Myosin Isolated From the Mouse Model of Familial Hypertrophic Cardiomyopathy
Circ. Res., April 14, 2000; 86(7): 737 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. A Palmiter, M. J Tyska, D. E Dupuis, N. R Alpert, and D. M Warshaw
Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms
J. Physiol., September 15, 1999; 519(3): 669 - 678.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Ruf, H. Schulte-Baukloh, J. Ludemann, H. Posival, F. Beyersdorf, H. Just, and C. Holubarsch
Alterations of cross-bridge kinetics in human atrial and ventricular myocardium
Cardiovasc Res, December 1, 1998; 40(3): 580 - 590.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L.A. Mulieri, W. Barnes, B.J. Leavitt, F.P. Ittleman, M.M. LeWinter, N.R. Alpert, and D.W. Maughan
Alterations of Myocardial Dynamic Stiffness Implicating Abnormal Crossbridge Function in Human Mitral Regurgitation Heart Failure
Circ. Res., January 11, 2002; 90(1): 66 - 72.
[Abstract] [Full Text] [PDF]